Quadria Capital is a private equity firm founded in 2012 and headquartered in Singapore, specializing in investments within the healthcare sector. The firm focuses on high-growth opportunities in South Asia and Southeast Asia, targeting mid-sized companies in healthcare delivery, life sciences, medical technology, and related services. By leveraging its team's extensive operational and transactional expertise, Quadria Capital aims to identify and invest in scalable healthcare organizations that can address the critical and growing healthcare needs in these rapidly developing economies. The firm's investment strategy is designed to generate substantial financial returns for its investors while contributing positively to the healthcare landscape in the regions it serves.
Aragen Life Sciences is a prominent discovery research and development organization in Asia, providing a comprehensive range of services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, catering to the needs of healthcare institutions and other sectors. With over a decade of experience in delivering innovative drug discovery and development services, Aragen is equipped with a team of skilled scientists and advanced technologies that enable them to achieve exceptional results for their clients. The organization employs approximately 2,400 professionals and serves a diverse global customer base, including prominent players in pharmaceuticals, agrochemicals, electronics, biotechnology, and academia. Aragen Life Sciences is recognized for its commitment to quality, speed, and affordability, consistently meeting and exceeding customer expectations in their research endeavors.
NephroPlus
Series F in 2024
NephroPlus is a network of dialysis centers focused on delivering quality dialysis services at affordable prices. The company employs standardized protocols, continuous training, and innovation to ensure optimal care for patients. Its facilities provide a range of treatments, including dialysis, kidney stone management, and arteriovenous fistula procedures, addressing various renal and urological disorders. Through its specialized approach, NephroPlus aims to enhance patient recovery and overall health outcomes.
MediBuddy
Venture Round in 2023
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.
Maxivision Super Speciality Eye Hospitals
Private Equity Round in 2023
Maxivision Super Speciality Eye Hospitals is a dedicated eye care facility that specializes in a wide range of vision treatments. The hospital provides comprehensive services including cataract surgery, refractive surgery, and treatment for conditions such as glaucoma, retina disorders, and corneal issues. Additionally, it caters to pediatric eye care and offers oculoplastic procedures. By focusing on advanced medical techniques and patient accessibility, Maxivision aims to enhance the quality of eye care available to the community.
Straits Orthopaedics
Acquisition in 2023
Straits Orthopaedics is a specialized supplier of contract manufacturing services for orthopedic implants. The company offers a range of comprehensive and post-machining services, producing a variety of products including implants, trauma devices, external fixation systems, cutting tools, and surgical instruments. Straits Orthopaedics caters to clients by delivering cost-effective solutions that maintain a high standard of quality, supporting the development of both simple components and complex assemblies in the orthopedic field.
MediBuddy
Series C in 2022
MediBuddy is a digital healthcare platform designed to provide seamless access to a variety of healthcare services, including online doctor consultations, lab tests, and medicine delivery. Its mission is to make quality healthcare accessible and affordable for everyone, regardless of time or location. The platform enables patients to consult with specialist doctors through calls or chat, share medical reports, and receive online consultations and prescriptions. With the capability to offer medical support within half an hour's notice, MediBuddy leverages technology to effectively connect patients with healthcare providers, thereby bridging the gap in healthcare accessibility.
Concung
Private Equity Round in 2022
Concung Corporation is an extremely fast growing technology company for mom & baby products with one new store opened every day with the annual growth rate of 70%. By the end of 2022, the revenue is more than $500 million USD with 1,000 stores & 10 flagship hubs. Concung has more than millions of e-commerce users. With the vision of providing good quality products for moms, babies and kids from newborn to 12 year old. Con Cung addressable market size is more than 50 millions of population. It positions to cover all products and services for this market. As a tech company, Con Cung develops strong IT infrastructure for its e-commerce, hub/retail network, supply chain and operation/sales automation. Concung also invests into Research and Development in order to manufacture and provide products that are suitable and superior to the local market in terms of quality and pricing. All of the products must follow strict safety standards. With its extremely efficient management capability, the company is highly profitable with minimal capital investment. Con Cung maintains profitable even at the first year of establishment and shows to be a resilient business even during the Covid-19 pandemics. Concung Corporation is dynamic and vibrant. The management team are mostly in the age of 30s. Many of them are now holding the director positions with highly competitive benefit packages. The corporate culture is transparent, result oriented and fast decision making. The company nurtures and supports the creativity and originality of ideas. The working environment allows talents to prosper and promote quickly.
Encube Ethicals
Private Equity Round in 2021
Encube Ethicals is a contract development and manufacturing organization that focuses on dermatology products, specializing in topical semisolid formulations. The company develops and manufactures a range of products, including anti-inflammatory agents, antifungals, antiseptics, antibiotics, antivirals, and moisturizers. By offering these formulations, Encube Ethicals plays a vital role in providing treatments for various topical disorders and diseases, thereby improving patient care in dermatological health.
Nobel Hygiene
Secondary Market in 2021
Nobel Hygiene Pvt. Ltd. is a Mumbai-based manufacturer of personal hygiene products, catering to the needs of families with a diverse range of offerings. Established in 2001, the company specializes in producing diapers, pull-ups, underpads, and inserts for adults, as well as baby diapers, nappy pads, and maternity pads. Its products are designed for various consumers, including those with medical conditions such as incontinence, prostate disorders, and other needs associated with disability or bedridden patients. Nobel Hygiene is recognized for its quality and reliability, marketed under the brand names FRIENDS and TEDDYY. The company has a strong distribution network across India, utilizing stockists, dealers, and retailers, and also exports its products to markets in Australia, Malaysia, the United Arab Emirates, and parts of Africa.
Hermina Hospital
Private Equity Round in 2021
Hermina Hospital is a private hospital group in Indonesia that specializes in maternal and child healthcare, offering a comprehensive range of medical services. Its offerings include gynecology, pediatrics, heart care, radiation oncology, men's health, and internal medicine. The hospital also provides complex surgical procedures, laboratory services, radiology, fertility treatments, and general health services. In addition, Hermina Hospital facilitates online consultations, enhancing accessibility for patients. The group's operations are primarily concentrated in the islands of Java, Kalimantan, Sulawesi, and Sumatera, with the majority of its revenue generated from the Java region.
AIG Hospital
Funding Round in 2019
AIG Hospitals is a Gastroenterology hospital that believes and preaches that excellence is a way of life. It offers transplant surgeries including Liver, Kidney, Heart, Pancreas, and Islet Cell. It believes in creating a positive and nurturing environment that is conducive to healing. It was founded in 1986 and is headquartered in Hyderabad, India.
Akums Drugs and Pharmaceuticals
Private Equity Round in 2019
Akums Drugs and Pharmaceuticals Limited, established in 2004, is a prominent Contract Development and Manufacturing Organization (CDMO) specializing in a wide range of pharmaceutical products. The company manufactures oral solids, oral liquids, injectables, cosmetics, ayurvedic products, and nutraceuticals, catering to both domestic and international markets. It provides comprehensive services that include formulation research and development, regulatory dossier preparation, and various testing services. Akums is also involved in the production and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company serves a diverse clientele, including notable firms such as Alembic Pharmaceuticals, Alkem Laboratories, Cipla, Dabur India, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries, among others.
Akums Drugs and Pharmaceuticals
Private Equity Round in 2019
Akums Drugs and Pharmaceuticals Limited, established in 2004, is a prominent Contract Development and Manufacturing Organization (CDMO) specializing in a wide range of pharmaceutical products. The company manufactures oral solids, oral liquids, injectables, cosmetics, ayurvedic products, and nutraceuticals, catering to both domestic and international markets. It provides comprehensive services that include formulation research and development, regulatory dossier preparation, and various testing services. Akums is also involved in the production and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company serves a diverse clientele, including notable firms such as Alembic Pharmaceuticals, Alkem Laboratories, Cipla, Dabur India, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries, among others.
Strand Life Sciences
Private Equity Round in 2018
Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, specializing in the development and marketing of diagnostic tests for cancer and inherited diseases. Founded in 2000, the company offers a wide range of services, including diagnostics for oncology, genetics, fertility, women's health, infectious diseases, and general wellness. Strand provides advanced bioinformatics solutions, such as variant curation and interpretation platforms, along with its StrandOmics software for actionable insights from genomic data. The firm operates a DNA sequencing lab and has established partnerships with over 100 hospitals in India, expanding its reach into the US market. Strand's innovative software, including GeneSpring and Avadis, is utilized by 1,400 research institutions worldwide. The company emphasizes personalized medicine by identifying hereditary cancer risks and enabling tailored surveillance and risk-reduction strategies for patients. With a team of approximately 200 employees, Strand Life Sciences continues to grow in response to increasing demand for its genomic testing and interpretation services.
Lablink (M) Sdn Bhd
Private Equity Round in 2018
Lablink (M) Sdn Bhd is a Kuala Lumpur-based company that operates medical laboratories across Malaysia. Founded in 1989, it specializes in providing a comprehensive array of medical laboratory services, including hematology, chemical pathology, immunology and serology, histology, medical microbiology, cytology, molecular diagnostics, and health screenings. The company offers specimen collection from private clinics and hospitals, as well as mobile laboratory services for walk-in customers. Lablink (M) Sdn Bhd functions as a subsidiary of Kumpulan Perubatan (Johor) Sdn. Bhd., reflecting its commitment to delivering quality healthcare solutions in the region.
FV Hospital
Private Equity Round in 2017
FV Hospital operates an outpatient clinic. Its special division of oncology named hope cancer center, obstetric and gynecology, pediatric, ophthalmology, gastroenterology and hepatology, and radiology department.
Health Care At Home India
Private Equity Round in 2017
Health Care At Home India Pvt Ltd. is a prominent provider of home healthcare services in India, established in 2012 and headquartered in Noida. The company offers a comprehensive range of services, including home physiotherapy, pulmonology, cardiac care, oncology, post-surgical care, and ICU services, all aimed at enhancing patient recovery in the comfort of their homes. With a team of qualified doctors and skilled professionals, Health Care At Home focuses on delivering affordable and accessible healthcare solutions tailored to individual needs. The company is backed by the Burman family, known for their longstanding legacy in the healthcare sector through Dabur, and draws on the clinical expertise of its founders from Health Care at Home UK, which has a significant market presence internationally. By integrating modern technology and personalized care, Health Care At Home India aspires to transform the home into a central hub for healthcare, providing quality services that prioritize patient comfort and convenience.
Concord Biotech
Private Equity Round in 2016
Concord Biotech Limited is a biopharmaceutical company based in Ahmedabad, India, specializing in the manufacture of active pharmaceutical ingredients (APIs) through fermentation and semi-synthetic processes. Established in 1984, the company offers a diverse range of products, including immunosuppressants, antibiotics, anti-obesity agents, anti-fungal treatments, and oncology medications. Notable products include tacrolimus, mycophenolate mofetil, vancomycin HCl, and temsirolimus, among others. In addition to its product offerings, Concord Biotech provides strain improvement and contract fermentation, research, and manufacturing services. With a global presence, the company is committed to the development, manufacturing, and commercialization of biopharmaceutical products, leveraging its research and development capabilities to advance healthcare solutions.
AIG Hospital
Series A in 2015
AIG Hospitals is a Gastroenterology hospital that believes and preaches that excellence is a way of life. It offers transplant surgeries including Liver, Kidney, Heart, Pancreas, and Islet Cell. It believes in creating a positive and nurturing environment that is conducive to healing. It was founded in 1986 and is headquartered in Hyderabad, India.
Asian Institute of Gastroentology
Private Equity Round in 2015
The Asian Institute of Gastroenterology offers medical gastroenterology, surgical gastroenterology, hepatology, interventional radiology, and medical and surgical ICU services.
Soho Global Health
Private Equity Round in 2015
Soho Global Health is a healthcare company specializing in the manufacturing and distribution of a diverse range of products, including pharmaceuticals, herbal remedies, proprietary medicines, and health foods. Operating under several brand names such as Curcuma Plus, Imboost, and Asthma Soho, the company caters to various segments including consumer health and professional products. It also provides services in branding, sales, marketing, and production. The distribution segment accounts for the majority of its revenue, reflecting the company's focus on delivering health-related products and services to a broad market.
Medica Superspecialty Hospital
Private Equity Round in 2013
Medica Superspecialty Hospital is a healthcare provider based in Kolkata, West Bengal, specializing in a range of medical services. The hospital offers treatments for cardiac sciences, neurological diseases, kidney diseases, orthopedic sciences, gastroenterology and GI surgery, critical care, ENT, and breast diseases. It operates a network of facilities designed to deliver critical treatments while ensuring patient care is both affordable and accessible. Medica Superspecialty Hospital is committed to providing healthcare services in a safe, comfortable environment, prioritizing transparency and ethical practices in its operations.
Capricorn Food Products India
Private Equity Round in 2013
Capricorn Food Products India Limited is a prominent food processing company based in Chennai, India, established in 1998. It specializes in the production and export of a diverse range of processed fruit and vegetable products, including mango pulp, tomato paste, and individually quick frozen (IQF) fruits and vegetables. The company's offerings cater to various sectors, enabling the manufacture of juices, packaged foods, dairy products, ice creams, and baby foods. Capricorn is recognized for its commitment to quality and innovation in the fruit and vegetable processing industry, and it exports its products to markets across Europe, the Middle East, Asia Pacific, Africa, and North America. With a focus on preserving the freshness and natural goodness of its ingredients, Capricorn Food Products has established itself as a key player in the global food industry, particularly in the processing of tropical fruits and vegetables.
Iconoculture
Venture Round in 2004
Iconoculture, Inc. is a consumer trend and market research firm based in Minneapolis, Minnesota, founded in 1992. The company offers a range of services designed to help businesses understand consumer behavior and market dynamics. Its key offerings include the U.S. Advisory Service, which provides access to a comprehensive cultural research database along with monthly e-bulletins and an annual trend report. Iconoculture also features Global View, catering to global brands and agencies, and Custom View, an interactive platform for tailored content. Additionally, the firm operates IconoCommunities, which are consumer-centric social networks that gauge consumer sentiments and motivations. The company's annual cultural trend conference, Iconosphere, highlights emerging trends, while Consumer Outlooks offer insights into specific demographics or market segments. Iconoculture also provides Custom Research and Consulting services tailored to client needs. As of 2010, Iconoculture operates as a subsidiary of Corporate Executive Board Co.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.